Panchsheel Organics Quarterly Results for Trading Insights
PANCHSHEEL • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹14 Cr
QMarch 2025
Panchsheel Organics Quarterly Results Key Highlights
- Revenue of ₹110 Cr in March 2025 (+0.0% vs March 2025, +1.9% vs March 2024)
- Net Profit of ₹14 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
- EBITDA of ₹21 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 16.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹10.47 in March 2025 (+0.0% vs March 2025)
Panchsheel Organics Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 106 | 110 | 108 | 104 | 69 | -3.6% | - |
| Net Profit (₹ Cr) | 12 | 14 | 14 | 14 | 8 | - | - |
| EBITDA (₹ Cr) | 19 | 21 | 21 | 21 | 13 | - | - |
| EPS (₹) | 9.30 | 10.47 | 10.71 | 12.78 | 8.33 | - | - |
| Operating Margin (%) | 16.0% | 16.0% | 18.0% | 19.0% | 19.0% | - | - |
Panchsheel Organics Share Price Trend Around Quarterly Results
Visualize Panchsheel Organics's 1-year price movement across quarterly results — ideal for logging trades in Panchsheel Organics share price
chart using Tickjournal. All values in ₹.
Related Pages for Panchsheel Organics
Additional stock information and data for PANCHSHEEL
Revenue Trend (₹ Cr)
March 2023
104
March 2024
108
March 2025
110
2026
106
Net Profit Trend (₹ Cr)
March 2023
14
March 2024
14
March 2025
14
2026
12
Operating Margin Trend (%)
March 2023
19.0%
March 2024
18.0%
March 2025
16.0%
2026
16.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Panchsheel Organics quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores